$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The glomerulus is a network of capillaries that performs the essential task of filtering blood to form urine1. Mesangial cells (MCs) are embedded within the mesangial matrix, situated between the glomerular capillaries, and are uniquely positioned to influence glomerular dynamics through their diverse functions2. MCs play crucial roles in the glomerulus, including glomerular development, structural support for glomerular capillaries, phagocytosis, and the production of the glomerular basement membrane matrix3. The study of mesangial cells is pivotal for advancing our understanding of renal physiology and pathology.
The involvement of mesangial cells in pathological conditions is also noteworthy. In response to glomerular injury or disease, such as diabetic nephropathy or glomerulonephritis, mesangial cells can proliferate and secrete excess extracellular matrix components, leading to glomerulosclerosis and impaired kidney function4,5. Understanding the functions and regulatory mechanisms of mesangial cells is, therefore, essential for developing therapeutic strategies for kidney diseases.
Murine mesangial cells enable researchers to model and explore the molecular and cellular processes involved in conditions such as IgA nephropathy6, diabetic nephropathy7, and focal segmental glomerulosclerosis (FSGS)8,9. Given their roles in renal fibrosis and inflammation, murine glomerular MCs are frequently used in clinical studies to assess the efficacy of therapeutic compounds9,10. Additionally, murine mesangial cells are an important tool for studying the effects of various signaling pathways on renal function, including the RhoA/ROCK pathway11 and the Transforming Growth Factor-beta (TGF-β) pathway12. These studies help elucidate how these signaling molecules contribute to the progression of kidney disease. Whether used for disease modeling, therapeutic development, or signal transduction research, murine MCs continue to serve as a crucial resource for advancing our understanding of kidney health and disease.
Mackay et al. established a method to acquire ex vivo cell lines of glomerular epithelial, mesangial, and endothelial cells from transgenic mice in 198813. Wilson and Stewart developed a method for isolating and purifying primary MCs from patient kidney tissue, which involves three rounds of sieving and extensive washing with media14. Menè and Stoppacciaro also proposed a method for isolating primary MCs from patient or rat kidney tissue. This technique involves two rounds of sieving, two needle pushes, and collagenase digestion. Cells obtained from 4-8 rat kidneys are plated on a six-well plate, though the yield is relatively low15. These methods necessitate the dissection of the kidneys into small pieces before processing. Additionally, these approaches take approximately 3-4 weeks to yield purified MCs.
Mice are the most frequently employed experimental animal models in research on renal diseases. However, a systematic method for isolating murine MCs is still lacking. In this study, we developed an optimized protocol for murine MCs isolation and ex vivo cell culture. This method can be employed when using primary murine kidney MCs for experimental research. Compared to previous methods, this approach eliminates the need for tissue cutting and sieving prior to digestion. Instead, the entire mouse kidney is ground using a cell grinder and directly digested with collagenase. The digestion solution is then sieved twice, with all cells collected on the second sieve and resuspended. This method allows two mouse kidneys to produce enough cells to seed two to three 100 mm culture dishes within 10 days. Purified MCs are subsequently obtained through culture and purification using a specialized media containing D-valine. These cells can be passaged multiple times, frozen, revived, and cultured without compromising cell growth or protein expression. The equipment required for these procedures is easily available for basic biomedical laboratories, and the entire process takes just 2-3 weeks to obtain the target cells. This method is suited for studies involving murine MCs to investigate kidney-related diseases or mechanisms, as it is efficient and time-saving.